Advancing Flow Chemistry in API Manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Advancing Flow Chemistry in API Manufacturing
Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.


Pharmaceutical Technology
Volume 37, Issue 4, pp. 78-82

References

1. P. Van Arnum, Pharm. Technol. (36), 7, 50 (2012).

2. J. Hamby, “API Synthesis, Formulation Development, and Manufacturing” supplement to Pharm. Technol. 34, s18–19 (2010).

3. N. Korman et al., “API Synthesis, Formulation Development, and Manufacturing” supplement to Pharm. Technol. 34 , s32–s36 (2010).

4. P. Van Arnum, Pharm. Technol. 35 (8), 52–56 (2011).

5. S.A. May et al., Org. Process Res. Dev. 16 (5), 982-1002 (2012).

6. M.D. Johnson et al., Org. Process Res. Dev. 16 (5), 1017-1038 (2012).

7. S.Y. Wong et al., Org. Process Res. Dev. , online, DOI: 10.1021/op400011s, Mar.17, 2013.

8. T. Noel et al., Agnew. Chem. Int. Ed. online, DOI: 10.1002/anie.201101480, 17 May 2011.

9. S.R. Ritter, Chem. & Eng. News 89 (23), 39 (2011).

10. C. Crosjean et al., Org. Process Res. Dev. 16 (5), 781-787 (2012).

11. T. Tsubugo, Y. Yamashita, and S. Kobayashi et al., Chem. Eur. J. 18 (43), 13624-13628 (2012).

12. T. N. Glasnov, J. Flow Chem. 3 (4), 135-141 (2012).

13. A. Nagaki et al., Chem. Eur. J. 18 (38), 11871-11875 (2012).

14. K. Terao et al., J. Flow Chem. 2 (3), 73-76 (2012).

15.M. Rueping, T. Bootwicha, and E. Sugiono, Beilstein J. Org. Chem. 8, 300-307 (2012).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here